CellCept Information
What's inside CellCept
CellCept Active Ingredients: mycophenolate mofetil, mycophenolate mofetil hydrochloride, details.| CellCept Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| CellCept 500 mg | tablet | oral | 1.0 each | OTC |
| CellCept 500 mg | powder for injection | intravenous | 1.0 each | OTC |
| CellCept 250 mg | capsule | oral | 1.0 each | OTC |
| CellCept 200 mg/mL | suspension | oral | 1.0 milliliter(s) | OTC |
Recent CellCept Side Effects
Posted by jlf about 1 year ago
I am being treated with Cellcept (1000 mg in the morning and 1000 mg in the evening) for pemphigus vulgaris. Although I am ...
Posted by housestuff about 1 year ago
I have problems with sinus infections, trouble breathing and wheezing while using cellcept. I was at one point so bad with si...
Posted by maxinep about 1 year ago
I was just placed on Cellecept last week- 500 Mg 4 times a day-
for my autoimmune muscular myopathy- I was a body builder 6...
CellCept in the News
Immunosuppressant Drug Causes Birth Defects - MedIndia
The findings of the study have suggested that MMF, commercially available as Cellcept, has potentially harmful effects on the foetus and may result in ...
Fri Feb 08 06:18:06 -0500 2008
CEO leaves Roche as top dog in Europe drugs sector - Guardian
"Roche's growth is very broadly based and, with the exception of CellCept, which is used in transplantation, none of our major products is facing patent ...
Tue Mar 04 11:59:14 -0500 2008
Kidneys Affected In 40 Percent Of People With Lupus - Medical News Today (press release)
... or in place of steroid treatments), such as cyclophosphamide (Cytoxan®), azathioprine (Imuran®), cyclosporin A, and mycophenolate mofetil (CellCept®). ...
Thu Mar 06 04:08:24 -0500 2008
CellCept Chemical Information
mycophenolate mofetil - The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties. Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis. In vivo, the active metabolite, MPA, reversibly inhibits inosine 5'-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides. MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)
mycophenolate mofetil hydrochloride
CellCept RSS Feed
